Jun-Young Heo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jun-Young Heo has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Eun-Gyo Jeong
Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry, Yangsan, Korea
1 shared publication - Hae Ryoun Park
Department of Oral Pathology, School of Dentistry, Pusan National University, Republic of Korea
1 shared publication - Hye-Mi Jeon
Dental Clinic Center, Pusan National University Hospital, Busan, Korea
1 shared publication - Ji-Su Kim
Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry, Yangsan, Korea
1 shared publication - Jin-Hwa Kim
Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry, Yangsan, Korea
1 shared publication - Kyung-Hee Kim
Department of Oral Medicine Busan Paik Hospital Inje University College of Medicine Busan Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (4) , 331-340
Local Injection of Growth Hormone for Temporomandibular Joint Osteoarthritis
Osteoarthritis (OA) of the temporomandibular joint (TMJ) elicits cartilage and subchondral bone defects. Growth hormone (GH) promotes chondrocyte growth. The aim of this study was to evaluate the efficacy of intra-articular injections of GH to treat TMJ-OA. Monosodium iodoacetate (MIA) was used to induce OA in the TMJs of rats. After confirming the induction of OA, recombinant human GH was injected into the articular cavities of rats. Concentrations of GH and IGF-1 were measured in the blood and synovial fluid, and OA grades of cartilage and subchondral bone degradation were recorded by histological examination and micro-computed tomography. MIA-induced OA in the rat TMJ upregulated insulin-like growth factor-1 (IGF-1) rather than GH levels. GH and IGF-1 concentrations were increased after local injection of GH, compared with controls. Locally injected GH lowered osteoarthritic scores in the cartilage and subchondral bone of the TMJ. Intra-articular injection of GH improved OA scores in rat TMJs in both cartilage and subchondral bone of the condyles without affecting condylar bone growth. These results suggest that intra-articular injection of human GH could be a suitable treatment option for TMJ-OA patients in the future.
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (4) , 331-340
Open AccessLocal Injection of Growth Hormone for Temporomandibular Joint Osteoarthritis
Osteoarthritis (OA) of the temporomandibular joint (TMJ) elicits cartilage and subchondral bone defects. Growth hormone (GH) promotes chondrocyte growth. The aim of this study was to evaluate the efficacy of intra-articular injections of GH to treat TMJ-OA. Monosodium iodoacetate (MIA) was used to induce OA in the TMJs of rats. After confirming the induction of OA, recombinant human GH was injected into the articular cavities of rats. Concentrations of GH and IGF-1 were measured in the blood and synovial fluid, and OA grades of cartilage and subchondral bone degradation were recorded by histological examination and micro-computed tomography. MIA-induced OA in the rat TMJ upregulated insulin-like growth factor-1 (IGF-1) rather than GH levels. GH and IGF-1 concentrations were increased after local injection of GH, compared with controls. Locally injected GH lowered osteoarthritic scores in the cartilage and subchondral bone of the TMJ. Intra-articular injection of GH improved OA scores in rat TMJs in both cartilage and subchondral bone of the condyles without affecting condylar bone growth. These results suggest that intra-articular injection of human GH could be a suitable treatment option for TMJ-OA patients in the future.